金吾财讯 | 联邦制药(03933)午后持续走弱，截止发稿，跌11.66%，报14.7港元，成交额6.92亿港元。据公司公告显示，于20204年，归母净利润26.60亿元(人民币，下同)，同比下降1.54%；收入137.59亿元，同比微增0.1%，毛利6.08亿元，同比下降4%；每股基本盈利146.39分。拟派末期股息每股28分，特别股息每股12分。分业务看，中间体及原料药收入分别为26.59亿元（同比+14.8%）和63.73亿元（同比-0.4%），海外销售占比19.2%；制剂产品收入47.28亿元，同比下降5.9%，主要受国家药品集采价格下调影响。其中，抗感染产品（人用）销售收入同比下降 23.6%至17.97亿元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.